Good morning, and welcome to Tarsus Year End 2024 Financial Results Conference Call. As a reminder, this call is being recorded. At this time, I would like to turn the call over to David Nakasone, ...
BofA lowered the firm’s price target on Tarsus Pharmaceuticals (TARS) to $70 from $75 and keeps a Buy rating on the shares. Q4 capped off a ...
The Lake Shore Shorians completed a three-game season sweep of the St. Clair Shores rival – the Lakeview Huskies – on Monday, ...
英为财情Investing.com - Tarsus (NASDAQ: TARS )星期二发布了第四季度的财报,数据显示,公司营收高于分析师的预期,每股收益超出了分析师的预期。 在该公司发布的最新财报中,公司每股收益为$-0.60,总营收为$66.41M,而此前英为财情Investing.com对分析师的调查显示,分析师预期该公司的营收为$57.53M,每股收益为$-0.77.
Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of 11.76% and 12.33%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...
Ten newly restored silent Laurel & Hardy shorts are getting a Blu-ray release as part of Eureka Entertainment’s The Masters of Cinema Series.
Barclays analyst Balaji Prasad maintained a Buy rating on Tarsus Pharmaceuticals (TARS – Research Report) today and set a price target of ...
Tarsus Pharmaceuticals Inc (NASDAQ:TARS) is set to release its Q4 2024 earnings on Feb 25, 2025. The consensus estimate for ...